FactEvidence 1
ipo proceeds$117 million
No public evidence summary is available.
BioPharma Dive · 2026-10-09 18:59
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
Company
TRex Bio
Structure of TRex Bio
TRex Bio
Company
2 connections
PeersCompetition and partners
Relationship began
TRex BioCompany · 2 connections
Layer 1PeersCompetition and partners2
Relations
Arrows show the direction of the relationship. Filter to focus on a business area.
- Company · Eli LillyEvidence 1Fact55%
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
- Company · Johnson & JohnsonEvidence 1Fact55%
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
- Eli Lillyowns →TRex BioCompany · Eli LillyEvidence 1Fact55%
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
Showing 1 to 3 of 3
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 1
shares sold in ipo8,333,334 shares
No public evidence summary is available.
BioPharma Dive · 2026-10-09 18:59
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
FactEvidence 1
ipo price per share$14
No public evidence summary is available.
BioPharma Dive · 2026-10-09 18:59
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
FactEvidence 1
ipo ticker symbolTRXB
No public evidence summary is available.
BioPharma Dive · 2026-10-09 18:59
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
FactEvidence 1
partners withEli Lilly
No public evidence summary is available.
BioPharma Dive · 2026-10-09 18:59
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
FactEvidence 1
partners withJohnson & Johnson
No public evidence summary is available.
BioPharma Dive · 2026-10-09 18:59
View evidence
- MediaBioPharma Dive2026-10-09 18:59View source
Showing 1 to 6 of 9
Market and valuation
Valuation data is available on Pro and Research.
Included in ProNot available: Company signals · Financials · Filings · Guidance